---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-061412"
form_type: "8-K"
ticker: "ATXI"
cik: "0001644963"
company_name: "AVENUE THERAPEUTICS, INC."
filed_at: "2022-05-16T23:59:59+00:00"
generated_at: "2026-06-25T14:58:40.447365+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Avenue Therapeutics enters stock contribution for Baergic Bio; Nasdaq non-compliance for audit committee

## Summary
- Entered stock contribution agreement with parent Fortress to acquire 100% of Baergic Bio; conditions include $7.5M equity financing and repurchase of InvaGen shares.
- Director Jay Kranzler determined not independent under Nasdaq rules; resigned from audit committee on May 13, 2022.
- Company notified Nasdaq of non-compliance with audit committee composition rule; cure period available under Nasdaq Rule 5605(c)(4).
- Faith L. Charles appointed to Board and audit committee to fill vacancies, effective May 16, 2022.

## SEC filing metadata
- accession: 0001104659-22-061412
- form_type: 8-K
- ticker: ATXI
- cik: 0001644963
- company_name: AVENUE THERAPEUTICS, INC.
- filed_at: 2022-05-16T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.01, 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1644963/000110465922061412/0001104659-22-061412-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1644963/000110465922061412/tm2215290d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-061412
- JSON: https://secwatch.observer/filing/0001104659-22-061412.json
- Plain text: https://secwatch.observer/filing/0001104659-22-061412.txt

## Key facts
- Executive change
  Faith L. Charles was appointed as director at AVENUE THERAPEUTICS, INC..
  - Action: appointed
  - Role: director
  source text: On May 16, 2022, the Board appointed Faith L. Charles as a director
  evidence_url: https://www.sec.gov/Archives/edgar/data/1644963/000110465922061412/0001104659-22-061412-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.